Toshiyuki Mori
Directeur/Membre du Conseil chez RIBOMIC INC.
Postes actifs de Toshiyuki Mori
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RIBOMIC INC. | Directeur/Membre du Conseil | 01/06/2019 | - |
| Independent Dir/Board Member | 01/06/2019 | - | |
Editforce, Inc.
 Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan. | Directeur/Membre du Conseil | 01/03/2019 | - |
J-Pharma Co., Ltd.
 J-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan. | Directeur/Membre du Conseil | 01/06/2020 | - |
Historique de carrière de Toshiyuki Mori
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RIBOMIC INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Editforce, Inc.
Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan. | Commercial Services |
J-Pharma Co., Ltd.
J-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan. | Health Technology |
- Bourse
- Insiders
- Toshiyuki Mori
- Expérience
